Brian Rowan
Oral & Maxillofacial Surgery · Boise, IDNPI 1710370903
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,203 of the $3,801 with a category attached, or 84.3%. 9 manufacturers reported payments, led by Straumann USA LLC at 53.6% of the total.
Across 68 payments — averaging $55.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Straumann USA LLC$2K
- Kls-martin L.p.$1K
- Stryker$432
- Nobel Biocare USA$84
- Henry Schein, Inc.$39
- AbbVie$29
- plus $65 from 3 others
What the payments were for
- Speaking & faculty fees$2316%
- Food & beverage$3,20384%
- Education$3108%
- Gifts$571%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Straumann USA LLC | 40 | $2,039 |
| Kls-martin L.p. | 16 | $1,112 |
| Stryker | 5 | $432 |
| Nobel Biocare USA | 1 | $84 |
| Henry Schein, Inc. | 2 | $39 |
| AbbVie | 1 | $29 |
| Johnson & Johnson | 1 | $29 |
| Dentsply Sirona Inc | 1 | $21 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NA$332
How this compares
$3,801 in reported general payments places this provider in the 85th percentile of 29 oral & maxillofacial surgery providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 85 | $839 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 153 | $715 |
| Chlorhexidine Gluconate | 195 | $656 |
| Clindamycin Hcl | 31 | $390 |
| Amoxicillin | 148 | $336 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 20 | $171 |
Paid to pharmacies, not to this prescriber.
Other oral & maxillofacial surgery in Boise
- Arman HaghighiBoise$11K
- Justin HastingsBoise$5K
- Devan MunkBoise$3K
- Timothy O'BrienBoise$2K
- Kevin KempersBoise$1K
- Christopher ManisBoise$854
- Michael BaileyBoise$619
- James ComstockBoise$513
- Dean YounceBoise$179
- Bruce MorrisonBoise$62
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.